HEADER HYDROLASE/INHIBITOR 13-APR-09 3H1P TITLE MATURE CASPASE-7 I213A WITH DEVD-CHO INHIBITOR BOUND TO ACTIVE SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CASP-7, ICE-LIKE APOPTOTIC PROTEASE 3, ICE-LAP3, APOPTOTIC COMPND 5 PROTEASE MCH-3, CMH-1; COMPND 6 EC: 3.4.22.60; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: N-ACETYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-N-[(2S)-1- COMPND 11 CARBOXY-3-HYDROXYPROPAN-2-YL]-L-VALINAMIDE; COMPND 12 CHAIN: C, D; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP7, MCH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSET; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS PROTEASE, COMPENSATORY MECHANISM, APOPTOSIS, CELL DEATH, CYSTEINE KEYWDS 2 PROTEASE, THIOL PROTEASE, ZYMOGEN, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.A.WITKOWSKI,J.A.HARDY REVDAT 8 22-NOV-23 3H1P 1 REMARK REVDAT 7 06-SEP-23 3H1P 1 REMARK REVDAT 6 13-OCT-21 3H1P 1 SEQADV LINK REVDAT 5 01-NOV-17 3H1P 1 REMARK REVDAT 4 05-OCT-11 3H1P 1 COMPND DBREF HEADER KEYWDS REVDAT 3 13-JUL-11 3H1P 1 VERSN REVDAT 2 07-JUL-09 3H1P 1 JRNL REVDAT 1 30-JUN-09 3H1P 0 JRNL AUTH W.A.WITKOWSKI,J.A.HARDY JRNL TITL L2' LOOP IS CRITICAL FOR CASPASE-7 ACTIVE SITE FORMATION. JRNL REF PROTEIN SCI. V. 18 1459 2009 JRNL REFN ISSN 0961-8368 JRNL PMID 19530232 JRNL DOI 10.1002/PRO.151 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 26470 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1328 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.61 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.68 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1821 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.15 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3798 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 0.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.342 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.265 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.194 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.418 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3875 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5211 ; 1.876 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 467 ; 8.410 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 195 ;38.012 ;24.513 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 687 ;19.869 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;21.707 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 554 ; 0.159 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2940 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1864 ; 0.279 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2577 ; 0.332 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 241 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 22 ; 0.273 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.277 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2387 ; 1.587 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3771 ; 2.775 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1651 ; 4.337 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1440 ; 6.543 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 60 A 300 4 REMARK 3 1 B 60 B 300 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1803 ; 0.410 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1803 ; 3.000 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3H1P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052580. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL MAX-FLUX REMARK 200 OPTICS : OSMIC MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26471 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.610 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 15.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.69400 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1F1J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 3350, 300MM DIAMMONIUM REMARK 280 HYDROGEN CITRATE, 10MM GUANIDINE HYDROCHLORIDE, AND 10MM DTT, PH REMARK 280 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.06733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.03367 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.03367 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.06733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 343 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-ALDEHYDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 50 REMARK 465 THR A 51 REMARK 465 ARG A 52 REMARK 465 ASP A 53 REMARK 465 ARG A 54 REMARK 465 VAL A 55 REMARK 465 PRO A 56 REMARK 465 THR A 57 REMARK 465 ALA A 197 REMARK 465 ASP A 198 REMARK 465 SER A 199 REMARK 465 GLY A 200 REMARK 465 PRO A 201 REMARK 465 ILE A 202 REMARK 465 ASN A 203 REMARK 465 ASP A 204 REMARK 465 THR A 205 REMARK 465 ASP A 206 REMARK 465 ALA A 207 REMARK 465 ASN A 208 REMARK 465 PRO A 209 REMARK 465 ARG A 210 REMARK 465 HIS A 304 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 HIS A 309 REMARK 465 THR B 50 REMARK 465 THR B 51 REMARK 465 ARG B 52 REMARK 465 ASP B 53 REMARK 465 ARG B 54 REMARK 465 VAL B 55 REMARK 465 PRO B 56 REMARK 465 ALA B 197 REMARK 465 ASP B 198 REMARK 465 SER B 199 REMARK 465 GLY B 200 REMARK 465 PRO B 201 REMARK 465 ILE B 202 REMARK 465 ASN B 203 REMARK 465 ASP B 204 REMARK 465 THR B 205 REMARK 465 ASP B 206 REMARK 465 ALA B 207 REMARK 465 ASN B 208 REMARK 465 PRO B 209 REMARK 465 ARG B 210 REMARK 465 HIS B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 195 CG1 CG2 CD1 REMARK 470 THR B 57 CA O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 196 O TYR B 211 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 100 CB CYS B 100 SG -0.107 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 122 CA - CB - CG ANGL. DEV. = -17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 77 -74.25 -104.64 REMARK 500 PHE A 78 114.13 80.63 REMARK 500 ASP A 113 62.71 14.04 REMARK 500 ASN A 148 2.98 80.06 REMARK 500 ARG A 187 12.91 -140.41 REMARK 500 PRO A 235 -38.78 -39.49 REMARK 500 SER A 277 149.33 -170.87 REMARK 500 ASP A 279 -23.60 94.56 REMARK 500 PRO A 280 -23.33 21.26 REMARK 500 GLU A 284 50.49 33.84 REMARK 500 SER A 302 -148.08 -110.98 REMARK 500 ARG B 87 77.85 -102.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 195 GLN A 196 134.50 REMARK 500 ASP A 279 PRO A 280 -143.02 REMARK 500 TYR B 151 GLY B 152 147.02 REMARK 500 ASP B 154 GLY B 155 -149.09 REMARK 500 GLN B 303 HIS B 304 136.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF N-ACETYL-L-ALPHA REMARK 800 -ASPARTYL-L-ALPHA-GLUTAMYL-N-[(2S)-1- CARBOXY-3-HYDROXYPROPAN-2- REMARK 800 YL]-L-VALINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF N-ACETYL-L-ALPHA REMARK 800 -ASPARTYL-L-ALPHA-GLUTAMYL-N-[(2S)-1- CARBOXY-3-HYDROXYPROPAN-2- REMARK 800 YL]-L-VALINAMIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL- REMARK 900 ASP-CHO REMARK 900 RELATED ID: 2QLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO REMARK 900 RELATED ID: 1SHJ RELATED DB: PDB REMARK 900 CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR REMARK 900 RELATED ID: 1K86 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CASPASE-7 DBREF 3H1P A 50 303 UNP P55210 CASP7_HUMAN 50 303 DBREF 3H1P B 50 303 UNP P55210 CASP7_HUMAN 50 303 DBREF 3H1P C 1 5 PDB 3H1P 3H1P 1 5 DBREF 3H1P D 1 5 PDB 3H1P 3H1P 1 5 SEQADV 3H1P SER A 171 UNP P55210 CYS 171 CONFLICT SEQADV 3H1P ALA A 213 UNP P55210 ILE 213 ENGINEERED MUTATION SEQADV 3H1P HIS A 304 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS A 305 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS A 306 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS A 307 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS A 308 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS A 309 UNP P55210 EXPRESSION TAG SEQADV 3H1P SER B 171 UNP P55210 CYS 171 CONFLICT SEQADV 3H1P ALA B 213 UNP P55210 ILE 213 ENGINEERED MUTATION SEQADV 3H1P HIS B 304 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS B 305 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS B 306 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS B 307 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS B 308 UNP P55210 EXPRESSION TAG SEQADV 3H1P HIS B 309 UNP P55210 EXPRESSION TAG SEQRES 1 A 260 THR THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET SEQRES 2 A 260 ASN PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN SEQRES 3 A 260 LYS ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN SEQRES 4 A 260 GLY THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE SEQRES 5 A 260 ARG SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SEQRES 6 A 260 SER CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER SEQRES 7 A 260 GLU GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE SEQRES 8 A 260 LEU LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS SEQRES 9 A 260 ASP GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE SEQRES 10 A 260 ARG GLY ASP ARG SER LYS THR LEU LEU GLU LYS PRO LYS SEQRES 11 A 260 LEU PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 12 A 260 ASP GLY ILE GLN ALA ASP SER GLY PRO ILE ASN ASP THR SEQRES 13 A 260 ASP ALA ASN PRO ARG TYR LYS ALA PRO VAL GLU ALA ASP SEQRES 14 A 260 PHE LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER SEQRES 15 A 260 TRP ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA SEQRES 16 A 260 LEU CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU SEQRES 17 A 260 ILE MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA SEQRES 18 A 260 ARG HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS SEQRES 19 A 260 GLU LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR SEQRES 20 A 260 LYS GLU LEU TYR PHE SER GLN HIS HIS HIS HIS HIS HIS SEQRES 1 B 260 THR THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET SEQRES 2 B 260 ASN PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN SEQRES 3 B 260 LYS ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN SEQRES 4 B 260 GLY THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE SEQRES 5 B 260 ARG SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SEQRES 6 B 260 SER CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER SEQRES 7 B 260 GLU GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE SEQRES 8 B 260 LEU LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS SEQRES 9 B 260 ASP GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE SEQRES 10 B 260 ARG GLY ASP ARG SER LYS THR LEU LEU GLU LYS PRO LYS SEQRES 11 B 260 LEU PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP SEQRES 12 B 260 ASP GLY ILE GLN ALA ASP SER GLY PRO ILE ASN ASP THR SEQRES 13 B 260 ASP ALA ASN PRO ARG TYR LYS ALA PRO VAL GLU ALA ASP SEQRES 14 B 260 PHE LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER SEQRES 15 B 260 TRP ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA SEQRES 16 B 260 LEU CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU SEQRES 17 B 260 ILE MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA SEQRES 18 B 260 ARG HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS SEQRES 19 B 260 GLU LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR SEQRES 20 B 260 LYS GLU LEU TYR PHE SER GLN HIS HIS HIS HIS HIS HIS SEQRES 1 C 5 ACE ASP GLU VAL ASJ SEQRES 1 D 5 ACE ASP GLU VAL ASJ HET ACE C 1 3 HET ASJ C 5 8 HET ACE D 1 3 HET ASJ D 5 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ASJ 2(C4 H9 N O3) FORMUL 5 HOH *119(H2 O) HELIX 1 1 ASP A 79 GLY A 83 5 5 HELIX 2 2 GLY A 89 GLY A 105 1 17 HELIX 3 3 SER A 115 GLU A 129 1 15 HELIX 4 4 ILE A 159 HIS A 165 1 7 HELIX 5 5 SER A 171 LEU A 175 5 5 HELIX 6 6 TRP A 240 GLY A 253 1 14 HELIX 7 7 GLU A 257 PHE A 273 1 17 HELIX 8 8 ASP B 79 GLY B 83 5 5 HELIX 9 9 GLY B 89 GLY B 105 1 17 HELIX 10 10 SER B 115 GLU B 129 1 15 HELIX 11 11 ILE B 159 HIS B 165 1 7 HELIX 12 12 SER B 171 LEU B 175 5 5 HELIX 13 13 TRP B 240 GLY B 253 1 14 HELIX 14 14 GLU B 257 PHE B 273 1 17 HELIX 15 15 ASP B 279 HIS B 283 5 5 SHEET 1 A12 PHE A 106 ASN A 112 0 SHEET 2 A12 LYS A 66 ASN A 74 1 N ILE A 72 O TYR A 111 SHEET 3 A12 ALA A 134 LEU A 142 1 O CYS A 136 N LEU A 67 SHEET 4 A12 LYS A 179 GLN A 184 1 O LEU A 180 N CYS A 139 SHEET 5 A12 PHE A 219 TYR A 223 1 O ALA A 222 N PHE A 181 SHEET 6 A12 CYS A 290 SER A 293 -1 O VAL A 292 N PHE A 221 SHEET 7 A12 CYS B 290 SER B 293 -1 O SER B 293 N VAL A 291 SHEET 8 A12 PHE B 219 TYR B 223 -1 N PHE B 221 O VAL B 292 SHEET 9 A12 LYS B 179 GLN B 184 1 N PHE B 181 O ALA B 222 SHEET 10 A12 PHE B 137 LEU B 142 1 N LEU B 141 O PHE B 182 SHEET 11 A12 GLY B 68 ASN B 74 1 N ILE B 71 O ILE B 140 SHEET 12 A12 PHE B 106 ASN B 112 1 O TYR B 111 N ILE B 72 SHEET 1 B 3 GLY A 145 GLU A 146 0 SHEET 2 B 3 VAL A 149 TYR A 151 -1 O VAL A 149 N GLU A 146 SHEET 3 B 3 VAL A 156 PRO A 158 -1 O THR A 157 N ILE A 150 SHEET 1 C 2 ARG A 233 SER A 234 0 SHEET 2 C 2 GLY A 238 SER A 239 -1 O GLY A 238 N SER A 234 SHEET 1 D 3 GLY B 145 GLU B 146 0 SHEET 2 D 3 VAL B 149 TYR B 151 -1 O VAL B 149 N GLU B 146 SHEET 3 D 3 VAL B 156 PRO B 158 -1 O THR B 157 N ILE B 150 SHEET 1 E 2 ARG B 233 SER B 234 0 SHEET 2 E 2 GLY B 238 SER B 239 -1 O GLY B 238 N SER B 234 LINK SG CYS A 186 C ASJ C 5 1555 1555 1.96 LINK SG CYS B 186 C ASJ D 5 1555 1555 1.82 LINK C ACE C 1 N ASP C 2 1555 1555 1.33 LINK C VAL C 4 N ASJ C 5 1555 1555 1.35 LINK C ACE D 1 N ASP D 2 1555 1555 1.36 LINK C VAL D 4 N ASJ D 5 1555 1555 1.33 SITE 1 AC1 13 ARG A 87 HIS A 144 GLY A 145 GLN A 184 SITE 2 AC1 13 CYS A 186 TYR A 230 SER A 231 TRP A 232 SITE 3 AC1 13 ARG A 233 SER A 234 PRO A 235 SER A 275 SITE 4 AC1 13 GLN A 276 SITE 1 AC2 13 ARG B 87 HIS B 144 GLY B 145 GLN B 184 SITE 2 AC2 13 CYS B 186 SER B 231 TRP B 232 ARG B 233 SITE 3 AC2 13 SER B 234 PRO B 235 GLN B 276 HOH D 26 SITE 4 AC2 13 HOH D 327 CRYST1 89.347 89.347 186.101 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011192 0.006462 0.000000 0.00000 SCALE2 0.000000 0.012924 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005373 0.00000